Sun Pharma gets non-exclusive rights to market second brand of Finerenone in India Ruchika Sharma19 Jan 2024 11:17 AM ISTBayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa.
Sun Pharma to acquire remaining stake in Taro Pharma Ruchika Sharma18 Jan 2024 2:03 PM ISTMumbai: Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. have announced that they have entered into a...
Sun Pharma Gets CDSCO Panel Nod for Additional Indication of Ranibizumab solution for injection Dr. Divya Colin16 Jan 2024 6:00 PM ISTNew Delhi: In line with the proposal presented by the drug major Sun Pharma, the Subject Expert Committee (SEC) functional under the Central Drug...
Conduct Phase III CT: CDSCO Panel Tells Sun Pharma on FDC Relugolix plus Estradiol plus Norethindrone Acetate Tablets Dr. Divya Colin10 Jan 2024 6:00 PM ISTNew Delhi: Citing that there is no safety and efficacy data on Indian population, the Subject Expert Committee (SEC) functional under the Central Drug...
Sun Pharma gets CDSCO Panel Nod To Manufacture and market antianxiety drug Etifoxine HCl Capsule Dr. Divya Colin2 Jan 2024 6:00 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Hyderabad: Spurious drugs racket busted, Rs 26 lakh stocks seized Ruchika Sharma2 Jan 2024 1:30 PM ISTSpurious/counterfeit drugs detected and seized by DCA officials include fake medicines which are falsely labeled under the names of reputed companies...
Sun Pharma to buy 16.7 percent stake in Lyndra Therapeutics for Rs 249 crore Ruchika Sharma19 Dec 2023 2:44 PM ISTThe transaction is expected to be completed by the end of December 2023, subject to certain conditions, Sun Pharma added.
Lupin, Sun Pharma recall rheumatoid arthritis, thyroid drugs in US Ruchika Sharma18 Dec 2023 11:45 AM ISTNew Delhi: Leading drugmakers Sun Pharma and Lupin are recalling products in the US market over manufacturing issues, as per the US Food and Drug...
Sun Pharma gets CDSCO panel nod to manufacture, and market Etifoxine HCL capsules for anxiety Susmita Roy16 Dec 2023 6:00 PM ISTNew Delhi: The drug major Sun Pharmaceuticals has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Sun Pharma Ilumetri now included in category B of China National Reimbursement Drug List Ruchika Sharma14 Dec 2023 2:43 PM ISTILUMETRI is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Sun Pharma, Torrent Pharma and 2 others undergoing USFDA inspections Ruchika Sharma6 Dec 2023 2:30 PM ISTHyderabad: The U.S. Food and Drug Administration is inspecting Dr Reddy's research and development centre in the southern Indian city of...
Sun Pharma arm signs licensing agreement with Aclaris Therapeutics Ruchika Sharma6 Dec 2023 12:30 PM ISTThe agreement includes an upfront payment of USD 15 million, regulatory and commercial milestones, and royalties.
